insiderwall
Menu
SuperinvestorInsider
Sinovac Biotech Ltd. SVA

Super Investor & Insider

Nessuna transazione insider negli ultimi 6 mesi.

Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.

About

Sinovac Biotech Ltd. is a prominent biotechnology company that specializes in the research, development, manufacturing, and commercialization of vaccines to address human infectious diseases. Headquartered in Beijing, China, Sinovac plays a critical role in the global health market by developing vaccines for illnesses

Sector
ExchangeNASDAQ
Industry
CountryUnited States
Employees0
TickerSVA

Statistics

Market Cap$464.9M
Revenue (TTM)$386.0M
Net Income-$198.8M
Net Margin-51.5%
EPS$-0.83
P/E6.66
P/S1.20
P/B0.10
EV/EBITDA9.35
ROE-0.9%
Dividend Yield
Price$6.47

Data: Twelve Data · Revenue = mcap / P/S